TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD

NYSEHealthcarePHARMACEUTICAL PREPARATIONS

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$18.2M10 sales
Net open-market−$18.2MBuying minus selling
Active insiders6Distinct reporting owners

TEVA transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Daniell Richard
Executive Vice President · EC
EVP, EC
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
Daniell Richard
Executive Vice President · EC
EVP, EC
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large disposal
Units disposed were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Daniell Richard
Executive Vice President · EC
EVP, EC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Repeat seller
The same owner reported more than one sale within 30 days.
+1
Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

SEC filing ↗
−$856kView disclosure →
Daniell Richard
Executive Vice President · EC
EVP, EC
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$694kView disclosure →
Daniell Richard
Executive Vice President · EC
EVP, EC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
+1
Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

SEC filing ↗
−$1.07MView disclosure →
Daniell Richard
Executive Vice President · EC
EVP, EC
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$868kView disclosure →
Francis Richard D
President
PRES
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
+2
Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

Pre-planned (10b5-1)

10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.

SEC filing ↗
−$10.6MView disclosure →
Sabag Mark
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
Sabag Mark
SR
SR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
+2
Repeat seller

The same owner reported more than one sale within 30 days.

Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

SEC filing ↗
−$1.97MView disclosure →
Sabag Mark
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$1.56MView disclosure →
Weiss Amir
CAO
CAO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
Weiss Amir
CAO
CAO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Repeat seller
The same owner reported more than one sale within 30 days.
+1
Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

SEC filing ↗
−$410kView disclosure →
Weiss Amir
CAO
CAO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Repeat seller
The same owner reported more than one sale within 30 days.
+1
Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

SEC filing ↗
−$305kView disclosure →
Weiss Amir
CAO
CAO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
SEC filing ↗
−$28.6kView disclosure →
Weiss Amir
CAO
CAO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$269kView disclosure →
Bergwerk Dov
CLO
CLO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Brailer David J
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Sabag Mark
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large disposal
Units disposed were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Sabag Mark
SR
SR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
+1
Large disposal

Units disposed were at least 25% of reported post-transaction holdings.

SEC filing ↗
−$1.93MView disclosure →
Sabag Mark
SR
SR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$1.61MView disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 12, 2026

Open-market transaction mix · 10 transactions in the selected period
0 buys0%·100%10 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026000$0$0$0
Nov 20260102$0$18,230,009.49−$18,230,009.49

Distinct insiders active

Reporting-owner CIKs by month · peak Nov 2026 (6)
Oct 2026: 0 insidersNov 2026: 6 insiders
Oct 2026Nov 2026
6distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
5 insiders
  • FD
    Francis Richard DPRES · 0 buys · 1 sale · 0 awards (A)
    −$10.6Mlast Nov 12
  • SM
    Sabag MarkSR · 0 buys · 2 sales · 0 awards (A)
    −$736klast Nov 12
  • WA
    Weiss AmirCAO · 0 buys · 3 sales · 0 awards (A)
    −$475klast Nov 12
  • DR
    Daniell RichardEVP, EC · 0 buys · 2 sales · 0 awards (A)
    −$367klast Nov 12
  • BD
    Bergwerk DovCLO · 0 buys · 0 sales · 1 award (A)
    $0last Nov 12
Filing, role and holdings details
Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale$10.6M
10b5-1 detected1
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
26transactionstxns
  • M · Option exercise · dominant14 · 54%
  • S · Open-market sells10 · 38%
  • A · Grants / awards2 · 7.7%

Activity by reported role

A joint filing can contribute to multiple roles
EC6
EVP6
ICLO6
SR6
CAO5
CLO1
Director1
PRES1

Reported Holdings After

Separated by insider, security, and ownership type

Bergwerk DovOrdinary Shares · Direct
29.4k11.9kNov 4, 2026Nov 4, 2026
11,943Nov 4, 2026
Sabag MarkOrdinary Shares · Direct
127k80.8kNov 5, 2026Nov 12, 2026
80,760Nov 12, 2026
Weiss AmirOrdinary Shares · Direct
20.8k3.54kNov 9, 2026Nov 9, 2026
3,537Nov 9, 2026
Daniell RichardOrdinary Shares · Direct
80.8k55.8kNov 9, 2026Nov 11, 2026
55,755Nov 11, 2026
Bergwerk DovStock Options (right to buy) · Direct
00Nov 4, 2026Nov 4, 2026
0Nov 4, 2026
Sabag MarkStock Options (right to buy) · Direct
44.7k0Nov 5, 2026Nov 12, 2026
0Nov 12, 2026
Daniell RichardStock Options (right to buy) · Direct
20.0k0Nov 9, 2026Nov 11, 2026
0Nov 11, 2026
Weiss AmirStock Options (right to buy) · Direct
00Nov 9, 2026Nov 9, 2026
0Nov 9, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
2 active days
Oct 16 → Nov 16
LessMore

TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at TEVA PHARMACEUTICAL INDUSTRIES LTD?

Daniell Richard, Francis Richard D, Sabag Mark, Weiss Amir, Bergwerk Dov, BRAILER DAVID J.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Sabag Mark reported a sale on Nov 12, 2026 valued at $1.97M. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $18,230,009.49. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.